ORIGINAL RESEARCH
Published on 19 Mar 2025
Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis
doi 10.3389/fmolb.2025.1510896
- 298 views